 <p><strong>Small Business FDA User Fee Adjustment Act of 2021</strong></p> <p>This bill reduces and waives certain fees related to marketing certain over-the-counter (OTC) drugs for businesses with fewer than 500 employees, including employees of affiliates.</p> <p>Starting in FY2022, the Food and Drug Administration (FDA) must waive the fee for the first OTC monograph order request from such a business. (Generally, an OTC monograph order request is a request for the FDA to evaluate whether a nonprescription drug meets certain standards.) </p> <p>The fee for each subsequent OTC monograph order request for such a business shall be 25% of the amount otherwise owed. </p> <p>For such a business, the FDA must also reduce the annual OTC monograph drug facility fee to 25% of the amount otherwise owed. (Generally, such a facility is engaged in the manufacturing or processing of an OTC monograph drug.)</p>